PRIALT

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug PRIALT contains one active pharmaceutical ingredient (API):

1	Ziconotide UNII T2I226K69M - ZICONOTIDE ACETATE
	Ziconotide is a synthetic analogue of a ω-conopeptide, MVIIA, found in the venom of the Conus magus marine snail. It is an N-type calcium channel blocker (NCCB). In binding to these neuronal NCCs ziconotide inhibits the voltage sensitive calcium current into primary nociceptive afferents terminating in the superficial layers of the dorsal horn of the spinal cord.
	Read more about Ziconotide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PRIALT Solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BG08	Ziconotide	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BG Other analgesics and antipyretics
Discover more medicines within N02BG08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1205244, 1205255, 1205266, 1368165
ES	Centro de información online de medicamentos de la AEMPS	04302001, 04302003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	071223, 071232
FR	Base de données publique des médicaments	66495139
GB	Medicines & Healthcare Products Regulatory Agency	106057, 106060
IT	Agenzia del Farmaco	037310012, 037310024, 037310036
LT	Valstybinė vaistų kontrolės tarnyba	1030403, 1030404, 1030405, 1030406
NL	Z-Index G-Standaard, PRK	98841
PL	Rejestru Produktów Leczniczych	100313279, 100313285
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51653001, W51653002, W51653003, W51656001
US	FDA, National Drug Code	18860-720, 18860-722, 18860-723, 70720-720, 70720-722, 70720-723